Literature DB >> 15004695

Molecular basis of facioscapulohumeral muscular dystrophy.

R Tupler1,2, D Gabellini3.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD), the third most common myopathy, is an autosomal dominant disease with an insidious onset and progression. Almost all FSHD patients carry deletions of an integral number of tandem 3.3 kb repeats, termed D4Z4, located on chromosome 4q35. In FSHD patients a deletion of the integral number of D4Z4 repeats generates a fragment that is usually smaller than 35 kb (fewer than 11 repeats), whereas in normal controls the size usually ranges from 50 to 300 kb (between 11 and 150 units). D4Z4 is a repetitive element with heterochromatic features. Recently, 4q35 genes located upstream of D4Z4 have been found to be inappropriately overexpressed specifically in FSHD muscle. An element within D4Z4 has been shown to behave as a silencer that provides a binding site for a transcriptional repressing complex. These results suggest a model in which deletion of D4Z4 leads to the inappropriate transcriptional derepression of 4q35 genes, resulting in disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004695     DOI: 10.1007/s00018-003-3285-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

1.  The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.

Authors:  Greta Forlani; Elisa Giarda; Ugo Ala; Ferdinando Di Cunto; Monica Salani; Rossella Tupler; Charlotte Kilstrup-Nielsen; Nicoletta Landsberger
Journal:  Hum Mol Genet       Date:  2010-05-26       Impact factor: 6.150

Review 2.  Epigenetics and human disease: translating basic biology into clinical applications.

Authors:  David Rodenhiser; Mellissa Mann
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

3.  Decreased nocturnal movements in patients with facioscapulohumeral muscular dystrophy.

Authors:  Giacomo Della Marca; Roberto Frusciante; Serena Dittoni; Catello Vollono; Anna Losurdo; Elisa Testani; Emanuele Scarano; Salvatore Colicchio; Elisabetta Iannaccone; Pietro A Tonali; Enzo Ricci
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

Review 4.  Alternative splicing and muscular dystrophy.

Authors:  Mariaelena Pistoni; Claudia Ghigna; Davide Gabellini
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

5.  Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases.

Authors:  Lina Shao; Chad A Shaw; Xin-Yan Lu; Trilochan Sahoo; Carlos A Bacino; Seema R Lalani; Pawel Stankiewicz; Svetlana A Yatsenko; Yinfeng Li; Sarah Neill; Amber N Pursley; A Craig Chinault; Ankita Patel; Arthur L Beaudet; James R Lupski; Sau W Cheung
Journal:  Am J Med Genet A       Date:  2008-09-01       Impact factor: 2.802

Review 6.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

Review 7.  Epigenetics and Human Disease.

Authors:  Huda Y Zoghbi; Arthur L Beaudet
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-02-01       Impact factor: 10.005

8.  Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy.

Authors:  Amber L Mueller; Andrea O'Neill; Takako I Jones; Anna Llach; Luis Alejandro Rojas; Paraskevi Sakellariou; Guido Stadler; Woodring E Wright; David Eyerman; Peter L Jones; Robert J Bloch
Journal:  Exp Neurol       Date:  2019-07-12       Impact factor: 5.330

9.  Increased resistance towards fatigability in patients with facioscapulohumeral muscular dystrophy.

Authors:  Matteo Beretta-Piccoli; Luca Calanni; Massimo Negro; Giulia Ricci; Cinzia Bettio; Marco Barbero; Angela Berardinelli; Gabriele Siciliano; Rossella Tupler; Emiliano Soldini; Corrado Cescon; Giuseppe D'Antona
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

10.  Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.

Authors:  Ebe Pastorello; Michelangelo Cao; Carlo P Trevisan
Journal:  Clin Neurol Neurosurg       Date:  2011-11-12       Impact factor: 1.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.